Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Azizi

Showing results (131-140 of 267) with videos related to

Pageof 27
Sort By:
Journal of Hypertension|August 16, 2019
Clinical characteristics, antihypertensive medication use and blood pressure control among patients with treatment-resistant hypertension: the Survey of PatIents with treatment ResIstant hyperTension studyCheryl Carcel, Bruce Neal, Suzanne Oparil, et al.
Journal of Hypertension|April 21, 2018
Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography-tandem mass spectrometry determinations of plasma aldosterone concentrationStephanie Baron, Laurence Amar, Anne-Laure Faucon, et al.
Hypertension (Dallas, Tex. : 1979)|January 12, 2026
Efficacy and Safety of Treatment With Low Doses of Spironolactone in Patients With Primary Aldosteronism: A Retrospective Observational Study in a Tertiary CenterElisa Sconfienza, Julien Riancho, Nicole Gebara, et al.
Journal of Hypertension|August 7, 2015
Carotid stiffness change over the cardiac cycle by ultrafast ultrasound imaging in healthy volunteers and vascular Ehlers-Danlos syndromeTristan Mirault, Mathieu Pernot, Michael Frank, et al.
Blood Pressure|February 26, 2024
Why were the 2023 Guidelines of the European Society of Hypertension not developed as Joint Guidelines together with the European Society of Cardiology?Reinhold Kreutz, Michel Azizi, Guido Grassi, et al.
Journal of Hypertension|July 18, 2018
European Society of Hypertension position paper on renal denervation 2018Roland E Schmieder, Felix Mahfoud, Michel Azizi, et al.
The Journal of Clinical Investigation|March 15, 2005
Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humansMichel Azizi, Pierre Boutouyrie, Alvine Bissery, et al.
European Heart Journal. Digital Health|January 30, 2023
Using social media to recruit study participants for a randomized trial for hypertensionLida Feyz, Yale Wang, Atul Pathak, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 3, 2014
Renal denervation with a percutaneous bipolar radiofrequency balloon catheter in patients with resistant hypertension: 6-month results from the REDUCE-HTN clinical studyHorst Sievert, Joachim Schofer, John Ormiston, et al.
Journal of the American College of Cardiology|January 21, 2026
Natriuretic Peptide Receptor-1 Agonist for Resistant Hypertension: A Randomized Phase 2 TrialWilliam B White, Michel Azizi, Keith Ferdinand, et al.
Pageof 27

Showing results (131-140 of 267) with videos related to

Sort By:
Pageof 27
Journal of Hypertension|August 16, 2019
Clinical characteristics, antihypertensive medication use and blood pressure control among patients with treatment-resistant hypertension: the Survey of PatIents with treatment ResIstant hyperTension studyCheryl Carcel, Bruce Neal, Suzanne Oparil, et al.
Journal of Hypertension|April 21, 2018
Criteria for diagnosing primary aldosteronism on the basis of liquid chromatography-tandem mass spectrometry determinations of plasma aldosterone concentrationStephanie Baron, Laurence Amar, Anne-Laure Faucon, et al.
Hypertension (Dallas, Tex. : 1979)|January 12, 2026
Efficacy and Safety of Treatment With Low Doses of Spironolactone in Patients With Primary Aldosteronism: A Retrospective Observational Study in a Tertiary CenterElisa Sconfienza, Julien Riancho, Nicole Gebara, et al.
Journal of Hypertension|August 7, 2015
Carotid stiffness change over the cardiac cycle by ultrafast ultrasound imaging in healthy volunteers and vascular Ehlers-Danlos syndromeTristan Mirault, Mathieu Pernot, Michael Frank, et al.
Blood Pressure|February 26, 2024
Why were the 2023 Guidelines of the European Society of Hypertension not developed as Joint Guidelines together with the European Society of Cardiology?Reinhold Kreutz, Michel Azizi, Guido Grassi, et al.
Journal of Hypertension|July 18, 2018
European Society of Hypertension position paper on renal denervation 2018Roland E Schmieder, Felix Mahfoud, Michel Azizi, et al.
The Journal of Clinical Investigation|March 15, 2005
Arterial and renal consequences of partial genetic deficiency in tissue kallikrein activity in humansMichel Azizi, Pierre Boutouyrie, Alvine Bissery, et al.
European Heart Journal. Digital Health|January 30, 2023
Using social media to recruit study participants for a randomized trial for hypertensionLida Feyz, Yale Wang, Atul Pathak, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 3, 2014
Renal denervation with a percutaneous bipolar radiofrequency balloon catheter in patients with resistant hypertension: 6-month results from the REDUCE-HTN clinical studyHorst Sievert, Joachim Schofer, John Ormiston, et al.
Journal of the American College of Cardiology|January 21, 2026
Natriuretic Peptide Receptor-1 Agonist for Resistant Hypertension: A Randomized Phase 2 TrialWilliam B White, Michel Azizi, Keith Ferdinand, et al.
Pageof 27